S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
London Exchange · UK · Updated after 19 Oct 2026 close

Emergent Biosolutions Inc.

0IGA · London Exchange · prices in USD
USD 6.460▼ -0.720 (10.03%)
Research reportHistorical data

About Emergent Biosolutions Inc.

Emergent BioSolutions is a specialty biopharmaceutical company based in Gaithersburg, Maryland, that develops and manufactures medical countermeasures against biological threats and infectious diseases. Its products include vaccines and antibody treatments for anthrax and other dangerous pathogens, along with contract manufacturing services for pharmaceutical and government customers. The company's main clients are government health and defense agencies, particularly in the United States, which stockpile its products for emergency preparedness.

Emergent Biosolutions Inc. trades under the code 0IGA on the London Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

12/ 100
Market X-Ray · price-based
Weak price profile
Ranks #3655 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
9/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-23.2%
From 52-week high-53.4%
MomentumWeak
15/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-14.8%
6-month return-25.7%
12-month, skipping last month-31.1%
Stability (higher is calmer)Weak
9/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)82.5%
Worst drawdown, 1 year (smaller is calmer)-67.9%
LiquidityWeak
19/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.02M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
Price trend
Below its 200-day average
Versus its 50- and 200-day averages
52-week range
4.370 – 13.906
Price is 22% of the way up
Returns
−14.8% 3m · −35.0% 1y
Price returns, dividends not included
RSI (14)
46
Neutral zone

Price chart

52-wk range 4.370 – 13.906 Daily closes, split-adjusted

Signals

50-day average6.071
200-day average8.410
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.428

Technical summary

Daily
Bearish
5 bullish · 1 neutral · 10 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 10 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 107.02Bearish
EMA 106.88Bearish
SMA 206.84Bearish
EMA 206.79Bearish
SMA 506.07Bullish
EMA 506.67Bearish
SMA 1007.04Bearish
EMA 1007.05Bearish
SMA 2008.41Bearish
EMA 2007.71Bearish
Oscillators (daily)
RSI (14)46.32Neutral
MACD (12, 26)0.15Bullish
Momentum (12)-2.85Bearish
Stochastic %K (14)15.82Bullish
Williams %R (14)-84.18Bullish
CCI (20)-148.1Bullish
Pivot points (classic, last session)
S3
6.04
S2
6.15
S1
6.30
Pivot
6.41
R1
6.56
R2
6.67
R3
6.82
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.

Prices are end-of-day closes in USD. Educational only, not financial advice.